Sirenko M

ORCID: 0000-0001-7816-8071 · 1 paper in corpus · active 2018
2018
Science advances ·doi:10.1126/sciadv.aaq1090

Patients with high-grade serous ovarian carcinoma (HGSC) exhibit poor 5-year survival rates, which may be significantly improved by early-stage detection. The U.S. Food and Drug Administration-approved biomarkers for HGSC-CA-125 (cancer ant…